Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 4/20 | 0.54 |
| ▸ | DRD2 | P14416 | 1/20 | 0.54 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.50 |
| ▸ | KDM1A | O60341 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30032791 | 1.00 | SLC6A4 (0.54) | SLC6A4DRD2MTNR1AKDM1AHRH3 | |
| SCHEMBL4047901 | 1.00 | SLC6A4 (0.54) | SLC6A4DRD2MTNR1AKDM1AHRH3 | |
| SCHEMBL497994 | 0.98 | SLC6A4 (0.56) | SLC6A4DRD2MTNR1AKDM1AHRH3 | |
| SCHEMBL3968194 | 0.94 | SLC6A4 (0.56) | SLC6A4DRD2MTNR1AKDM1AHRH3 | |
| SCHEMBL30477104 | 0.89 | SLC6A4 (0.59) | SLC6A4DRD2MTNR1AKDM1AHRH3 | |
| SCHEMBL248440 | 0.89 | SLC6A4 (0.59) | SLC6A4DRD2MTNR1AKDM1AHRH3 | |
| SCHEMBL7746921 | 0.89 | HPRT1 (0.50) | SLC6A4DRD2MTNR1AKDM1AHRH3 | |
| SCHEMBL23301397 | 0.85 | HPRT1 (0.50) | SLC6A4DRD2MTNR1AKDM1ACYP1B1 | |
| SCHEMBL6567045 | 0.82 | HPRT1 (0.52) | SLC6A4DRD2MTNR1AKDM1ACYP1B1 | |
| SCHEMBL30129727 | 0.82 | CYP1B1 (0.43) | SLC6A4DRD2KDM1ACYP1B1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115594652-A | Amine compound and organic light-emitting device thereof | 长春海谱润斯科技股份有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-115424682-A | Ethylene oligomerization catalyst molecule design method based on machine learning | 华东理工大学 | 2022-12-02 | — | — | CN | claimed |
| CN-115417806-A | Carbazole compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2022-12-02 | — | — | CN | claimed |
| CN-114907217-A | Triamine compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2022-08-16 | — | — | CN | claimed |
| CN-114773286-A | Nitrogen-containing heterocyclic organic compound and organic light-emitting device thereof | 长春海谱润斯科技股份有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-114656434-A | Tetramine compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2022-06-24 | — | — | CN | claimed |
| CN-114621181-A | Star-shaped tetramine derivative and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-114573536-A | Star triarylamine derivative and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| US-11021501-B2 | Creatine phosphate analog prodrugs, compositions and methods of use thereof | Farmington Pharma Development (US) | 2021-06-01 | — | — | US | claimed |
| CN-108516919-B | Preparation method of cyclohexyl derivative of naphthalene | 吉林化工学院 | 2021-04-13 | — | — | CN | claimed |
| EP-1654225-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONISTS | Amgen, Inc. (US) | 2006-05-10 | — | — | EP | claimed |
| US-20050256161-A1 | Melanin concentrating hormone receptor antagonists | AMGEN INC. | 2005-11-17 | — | — | US | claimed |
| WO-2005019240-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONISTS | AMGEN, INC. (US) | 2005-03-03 | — | — | WO | claimed |
| US-5679282-A | Chiral 2,6-difluorobenzene derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1997-10-21 | — | — | US | claimed |
| US-5043093-A | Liquid crystals | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1991-08-27 | — | — | US | claimed |
| EP-0152808-B1 | NITROGEN CONTAINING HETEROCYCLES | MERCK PATENT GmbH (DE) | 1990-09-12 | — | — | EP | claimed |
| EP-0209622-B1 | HYDROTERPHENYLS | MERCK PATENT GmbH (DE) | 1989-06-07 | — | — | EP | claimed |
| US-4702562-A | MIXTURE-FOR MULTIPLEXING | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1987-10-27 | — | — | US | claimed |
| US-4576850-A | STABLE BODY FORMED BY FOLDS; FREE-STANDING | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1986-03-18 | — | — | US | claimed |
| US-4459391-A | Method of making and a polymer of heat resistant polyester using diglycidil substituted diimides | UNITIKA LIMITED (JP) | 1984-07-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256161-A1 | Melanin concentrating hormone receptor antagonists | MCHR1, MC1R, NPY1R | SLC6A4 158/4885DRD2 182/4885MTNR1A 16/4885 |
| US-11021501-B2 | Creatine phosphate analog prodrugs, compositions and methods of use thereof | CKMT1A; CKMT1B, SLC2A1, SLC2A4 | SLC6A4 361/4885DRD2 4483/4885MTNR1A 2464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.